Global Point-of-Care Molecular Diagnostics Market Size study & Forecast, by Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Other Applications), by Technology (PCR, Genetic Sequencing, Hybridization, and Microarray), by End-User (Hospitals, Homecare, and Other End-Users) and Regional Analysis, 2022-2029
Global Point-of-Care Molecular Diagnostics Market is valued at approximately USD 3.05 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 11.43% over the forecast period 2022-2029. Point-of-care testing (POCT) is a type of examination in which the study is carried out at the site where medical care is provided to the patient. The Point-of-Care Molecular Diagnostics market is expanding because of factors such as increasing incidence of chronic diseases and rising demand for Point-of-Care Molecular Diagnostics.
According to the March 2020 report of the European Centre for Disease Control and Prevention, 52,862 new tuberculosis cases were reported in 2018 in 30 EU and European Economic Area (EU/EEA) nations, with a reporting rate of 10.2 per 100,000 individuals in the EU/EEA, A DNA amplification test, culture, or smear verified 36,047 cases of tuberculosis out of the total diagnosed cases in 2018. (Polymerase chain reaction test). However, lack of high-complexity test centers in POC molecular testing and uncertain reimbursement scenarios may halt market growth. Further, the market for the Global Point-of-Care Molecular Diagnostics may be fueled by Advancements in Formulation and investments in the R&D center
The key regions considered for the Global Point-of-Care Molecular Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to rising prevalence of cancer. For instance: According to National Cancer Institute, the number of cancer patients went from 18.1 million cases, in the year 2018 to 29.5 million cases, by the year 2040. Whereas, Asia Pacific is expected to grow significantly during the forecast period, owing to emergence of established players in the region.
?
Major market players included in this report are:
Meridian Bioscience Inc
Abbott Laboratories
Siemens Healthineers
F. Hoffmann-La Roche Ltd
Becton, Dickinson, and Company
Danaher Corporation
BioMerieux
Agilent Technologies
OraSure Technologies Inc.
Thermo Fisher Scientific
Recent Developments in the Market:
For the commercialization of the Veros COVID-19 test in the UK, Sense Biodetection and Una Health (Una) entered into a strategic partnership in February 2022. The main aim of this partnership agreement was to provide the end-users with various innovative solutions.
FIND invested USD 21 million in Biomeme, Bioneer, Qlife, and SD Biosensor in December 2021 to accelerate research, manufacturing, and release of low-cost point-of-care molecular detection platforms that can identify a number of disease-causing pathogens, including COVID-19.
Global Point-of-Care Molecular Diagnostics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Application, Technology, End-User and Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
PCR
Genetic Sequencing
Hybridization
Microarray
By Application:
Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Other Applications
By End-User:
Hospitals
Homecare
Other End-Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
According to the March 2020 report of the European Centre for Disease Control and Prevention, 52,862 new tuberculosis cases were reported in 2018 in 30 EU and European Economic Area (EU/EEA) nations, with a reporting rate of 10.2 per 100,000 individuals in the EU/EEA, A DNA amplification test, culture, or smear verified 36,047 cases of tuberculosis out of the total diagnosed cases in 2018. (Polymerase chain reaction test). However, lack of high-complexity test centers in POC molecular testing and uncertain reimbursement scenarios may halt market growth. Further, the market for the Global Point-of-Care Molecular Diagnostics may be fueled by Advancements in Formulation and investments in the R&D center
The key regions considered for the Global Point-of-Care Molecular Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to rising prevalence of cancer. For instance: According to National Cancer Institute, the number of cancer patients went from 18.1 million cases, in the year 2018 to 29.5 million cases, by the year 2040. Whereas, Asia Pacific is expected to grow significantly during the forecast period, owing to emergence of established players in the region.
?
Major market players included in this report are:
Meridian Bioscience Inc
Abbott Laboratories
Siemens Healthineers
F. Hoffmann-La Roche Ltd
Becton, Dickinson, and Company
Danaher Corporation
BioMerieux
Agilent Technologies
OraSure Technologies Inc.
Thermo Fisher Scientific
Recent Developments in the Market:
For the commercialization of the Veros COVID-19 test in the UK, Sense Biodetection and Una Health (Una) entered into a strategic partnership in February 2022. The main aim of this partnership agreement was to provide the end-users with various innovative solutions.
FIND invested USD 21 million in Biomeme, Bioneer, Qlife, and SD Biosensor in December 2021 to accelerate research, manufacturing, and release of low-cost point-of-care molecular detection platforms that can identify a number of disease-causing pathogens, including COVID-19.
Global Point-of-Care Molecular Diagnostics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Application, Technology, End-User and Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
PCR
Genetic Sequencing
Hybridization
Microarray
By Application:
Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Other Applications
By End-User:
Hospitals
Homecare
Other End-Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Point-of-Care Molecular Diagnostics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Point-of-Care Molecular Diagnostics Market, by Application, 2019-2029 (USD Billion)
1.2.3. Point-of-Care Molecular Diagnostics Market, by Technology, 2019-2029 (USD Billion)
1.2.4. Point-of-Care Molecular Diagnostics Market, by End-User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET DYNAMICS
3.1. Point-of-Care Molecular Diagnostics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of chronic diseases
3.1.1.2. Rising Demand for Point-of-care Diagnostics
3.1.2. Market Challenges
3.1.2.1. A lack of high-complexity test centres in POC molecular testing
3.1.2.2. Uncertain reimbursement scenarios
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation
3.1.3.2. Investments in the R&D centre
CHAPTER 4. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Point-of-Care Molecular Diagnostics Market by Application, Performance – Potential Analysis
6.3. Global Point-of-Care Molecular Diagnostics Market Estimates & Forecasts by Application, 2019-2029 (USD Billion)
6.4. Point-of-Care Molecular Diagnostics Market, Sub Segment Analysis
6.4.1. Oncology
6.4.2. Infectious Diseases
6.4.3. Hematology
6.4.4. Endocrinology
6.4.5. Other Applications
6.4.6. Prenatal Testing
CHAPTER 7. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY
7.1. Market Snapshot
7.2. Global Point-of-Care Molecular Diagnostics Market by Technology, Performance - Potential Analysis
7.3. Global Point-of-Care Molecular Diagnostics Market Estimates & Forecasts by Technology, 2019-2029 (USD Billion)
7.4. Point-of-Care Molecular Diagnostics Market, Sub Segment Analysis
7.4.1. PCR
7.4.2. Genetic Sequencing
7.4.3. Hybridization
7.4.4. Microarray
CHAPTER 8. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Point-of-Care Molecular Diagnostics Market by End-User, Performance - Potential Analysis
8.3. Global Point-of-Care Molecular Diagnostics Market Estimates & Forecasts by End-User, 2019-2029 (USD Billion)
8.4. Point-of-Care Molecular Diagnostics Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Homecare
8.4.3. Other End-Users
CHAPTER 9. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, REGIONAL ANALYSIS
9.1. Point-of-Care Molecular Diagnostics Market, Regional Market Snapshot
9.2. North America Point-of-Care Molecular Diagnostics Market
9.2.1. U.S. Point-of-Care Molecular Diagnostics Market
9.2.1.1. Application breakdown estimates & forecasts, 2019-2029
9.2.1.2. Technology breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Point-of-Care Molecular Diagnostics Market
9.3. Europe Point-of-Care Molecular Diagnostics Market Snapshot
9.3.1. U.K. Point-of-Care Molecular Diagnostics Market
9.3.2. Germany Point-of-Care Molecular Diagnostics Market
9.3.3. France Point-of-Care Molecular Diagnostics Market
9.3.4. Spain Point-of-Care Molecular Diagnostics Market
9.3.5. Italy Point-of-Care Molecular Diagnostics Market
9.3.6. Rest of Europe Point-of-Care Molecular Diagnostics Market
9.4. Asia-Pacific Point-of-Care Molecular Diagnostics Market Snapshot
9.4.1. China Point-of-Care Molecular Diagnostics Market
9.4.2. India Point-of-Care Molecular Diagnostics Market
9.4.3. Japan Point-of-Care Molecular Diagnostics Market
9.4.4. Australia Point-of-Care Molecular Diagnostics Market
9.4.5. South Korea Point-of-Care Molecular Diagnostics Market
9.4.6. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market
9.5. Latin America Point-of-Care Molecular Diagnostics Market Snapshot
9.5.1. Brazil Point-of-Care Molecular Diagnostics Market
9.5.2. Mexico Point-of-Care Molecular Diagnostics Market
9.6. Rest of The World Point-of-Care Molecular Diagnostics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Meridian Bioscience Inc
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Abbott Laboratories
10.2.3. Siemens Healthineers
10.2.4. F. Hoffmann-La Roche Ltd
10.2.5. Becton, Dickinson, and Company
10.2.6. Danaher Corporation
10.2.7. BioMerieux
10.2.8. Agilent Technologies
10.2.9. OraSure Technologies Inc.
10.2.10. Thermo Fisher Scientific
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Point-of-Care Molecular Diagnostics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Point-of-Care Molecular Diagnostics Market, by Application, 2019-2029 (USD Billion)
1.2.3. Point-of-Care Molecular Diagnostics Market, by Technology, 2019-2029 (USD Billion)
1.2.4. Point-of-Care Molecular Diagnostics Market, by End-User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET DYNAMICS
3.1. Point-of-Care Molecular Diagnostics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of chronic diseases
3.1.1.2. Rising Demand for Point-of-care Diagnostics
3.1.2. Market Challenges
3.1.2.1. A lack of high-complexity test centres in POC molecular testing
3.1.2.2. Uncertain reimbursement scenarios
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation
3.1.3.2. Investments in the R&D centre
CHAPTER 4. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Point-of-Care Molecular Diagnostics Market by Application, Performance – Potential Analysis
6.3. Global Point-of-Care Molecular Diagnostics Market Estimates & Forecasts by Application, 2019-2029 (USD Billion)
6.4. Point-of-Care Molecular Diagnostics Market, Sub Segment Analysis
6.4.1. Oncology
6.4.2. Infectious Diseases
6.4.3. Hematology
6.4.4. Endocrinology
6.4.5. Other Applications
6.4.6. Prenatal Testing
CHAPTER 7. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY
7.1. Market Snapshot
7.2. Global Point-of-Care Molecular Diagnostics Market by Technology, Performance - Potential Analysis
7.3. Global Point-of-Care Molecular Diagnostics Market Estimates & Forecasts by Technology, 2019-2029 (USD Billion)
7.4. Point-of-Care Molecular Diagnostics Market, Sub Segment Analysis
7.4.1. PCR
7.4.2. Genetic Sequencing
7.4.3. Hybridization
7.4.4. Microarray
CHAPTER 8. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Point-of-Care Molecular Diagnostics Market by End-User, Performance - Potential Analysis
8.3. Global Point-of-Care Molecular Diagnostics Market Estimates & Forecasts by End-User, 2019-2029 (USD Billion)
8.4. Point-of-Care Molecular Diagnostics Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Homecare
8.4.3. Other End-Users
CHAPTER 9. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, REGIONAL ANALYSIS
9.1. Point-of-Care Molecular Diagnostics Market, Regional Market Snapshot
9.2. North America Point-of-Care Molecular Diagnostics Market
9.2.1. U.S. Point-of-Care Molecular Diagnostics Market
9.2.1.1. Application breakdown estimates & forecasts, 2019-2029
9.2.1.2. Technology breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Point-of-Care Molecular Diagnostics Market
9.3. Europe Point-of-Care Molecular Diagnostics Market Snapshot
9.3.1. U.K. Point-of-Care Molecular Diagnostics Market
9.3.2. Germany Point-of-Care Molecular Diagnostics Market
9.3.3. France Point-of-Care Molecular Diagnostics Market
9.3.4. Spain Point-of-Care Molecular Diagnostics Market
9.3.5. Italy Point-of-Care Molecular Diagnostics Market
9.3.6. Rest of Europe Point-of-Care Molecular Diagnostics Market
9.4. Asia-Pacific Point-of-Care Molecular Diagnostics Market Snapshot
9.4.1. China Point-of-Care Molecular Diagnostics Market
9.4.2. India Point-of-Care Molecular Diagnostics Market
9.4.3. Japan Point-of-Care Molecular Diagnostics Market
9.4.4. Australia Point-of-Care Molecular Diagnostics Market
9.4.5. South Korea Point-of-Care Molecular Diagnostics Market
9.4.6. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market
9.5. Latin America Point-of-Care Molecular Diagnostics Market Snapshot
9.5.1. Brazil Point-of-Care Molecular Diagnostics Market
9.5.2. Mexico Point-of-Care Molecular Diagnostics Market
9.6. Rest of The World Point-of-Care Molecular Diagnostics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Meridian Bioscience Inc
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Abbott Laboratories
10.2.3. Siemens Healthineers
10.2.4. F. Hoffmann-La Roche Ltd
10.2.5. Becton, Dickinson, and Company
10.2.6. Danaher Corporation
10.2.7. BioMerieux
10.2.8. Agilent Technologies
10.2.9. OraSure Technologies Inc.
10.2.10. Thermo Fisher Scientific
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Point-of-Care Molecular Diagnostics Market, report scope
TABLE 2. Global Point-of-Care Molecular Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Point-of-Care Molecular Diagnostics Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 4. Global Point-of-Care Molecular Diagnostics Market estimates & forecasts by Technology 2019-2029 (USD Billion)
TABLE 5. Global Point-of-Care Molecular Diagnostics Market estimates & forecasts by End-User 2019-2029 (USD Billion)
TABLE 6. Global Point-of-Care Molecular Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Point-of-Care Molecular Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Point-of-Care Molecular Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Point-of-Care Molecular Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Point-of-Care Molecular Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Point-of-Care Molecular Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Point-of-Care Molecular Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Point-of-Care Molecular Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Point-of-Care Molecular Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Point-of-Care Molecular Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Point-of-Care Molecular Diagnostics Market
TABLE 71. List of primary sources, used in the study of global Point-of-Care Molecular Diagnostics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Point-of-Care Molecular Diagnostics Market, report scope
TABLE 2. Global Point-of-Care Molecular Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Point-of-Care Molecular Diagnostics Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 4. Global Point-of-Care Molecular Diagnostics Market estimates & forecasts by Technology 2019-2029 (USD Billion)
TABLE 5. Global Point-of-Care Molecular Diagnostics Market estimates & forecasts by End-User 2019-2029 (USD Billion)
TABLE 6. Global Point-of-Care Molecular Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Point-of-Care Molecular Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Point-of-Care Molecular Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Point-of-Care Molecular Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Point-of-Care Molecular Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Point-of-Care Molecular Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Point-of-Care Molecular Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Point-of-Care Molecular Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Point-of-Care Molecular Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Point-of-Care Molecular Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Point-of-Care Molecular Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Point-of-Care Molecular Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Point-of-Care Molecular Diagnostics Market
TABLE 71. List of primary sources, used in the study of global Point-of-Care Molecular Diagnostics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Point-of-Care Molecular Diagnostics Market, research methodology
FIG 2. Global Point-of-Care Molecular Diagnostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Point-of-Care Molecular Diagnostics Market, key trends 2021
FIG 5. Global Point-of-Care Molecular Diagnostics Market, growth prospects 2022-2029
FIG 6. Global Point-of-Care Molecular Diagnostics Market, porters 5 force model
FIG 7. Global Point-of-Care Molecular Diagnostics Market, pest analysis
FIG 8. Global Point-of-Care Molecular Diagnostics Market, value chain analysis
FIG 9. Global Point-of-Care Molecular Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Point-of-Care Molecular Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Point-of-Care Molecular Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Point-of-Care Molecular Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Point-of-Care Molecular Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Point-of-Care Molecular Diagnostics Market, regional snapshot 2019 & 2029
FIG 15. North America Point-of-Care Molecular Diagnostics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Point-of-Care Molecular Diagnostics Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Point-of-Care Molecular Diagnostics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Point-of-Care Molecular Diagnostics Market 2019 & 2029 (USD Billion)
FIG 19. Global Point-of-Care Molecular Diagnostics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Point-of-Care Molecular Diagnostics Market, research methodology
FIG 2. Global Point-of-Care Molecular Diagnostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Point-of-Care Molecular Diagnostics Market, key trends 2021
FIG 5. Global Point-of-Care Molecular Diagnostics Market, growth prospects 2022-2029
FIG 6. Global Point-of-Care Molecular Diagnostics Market, porters 5 force model
FIG 7. Global Point-of-Care Molecular Diagnostics Market, pest analysis
FIG 8. Global Point-of-Care Molecular Diagnostics Market, value chain analysis
FIG 9. Global Point-of-Care Molecular Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Point-of-Care Molecular Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Point-of-Care Molecular Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Point-of-Care Molecular Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Point-of-Care Molecular Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Point-of-Care Molecular Diagnostics Market, regional snapshot 2019 & 2029
FIG 15. North America Point-of-Care Molecular Diagnostics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Point-of-Care Molecular Diagnostics Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Point-of-Care Molecular Diagnostics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Point-of-Care Molecular Diagnostics Market 2019 & 2029 (USD Billion)
FIG 19. Global Point-of-Care Molecular Diagnostics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
